J&J Aims To Convert 5% Of U.S. Spinal Fusion Market To Charité In 2005
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/DePuy will train 2,000 U.S. spine surgeons to implant Charité artificial lumbar discs within the first year of approval, the firm says